Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1829-1843, doi:10.1016/j.jacc.2007.11.080
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gasparyan, A. Y.
Right arrow Articles by Lip, G. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gasparyan, A. Y.
Right arrow Articles by Lip, G. Y.H.

The Role of Aspirin in Cardiovascular Prevention

Implications of Aspirin Resistance

Armen Yuri Gasparyan, MD, PhD, Timothy Watson, MRCP and Gregory Y.H. Lip, MD, FRCP*

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom.


Figure 1
View larger version (63K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Inhibition of Platelet Thromboxane A2 Pathways by Low-Dose Aspirin

Figure illustration by Rob Flewell.

 

Figure 2
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Role of COX-1–Related and Nonrelated Mechanisms of Aspirin Resistance in Several Clinical Conditions

Figure illustration by Rob Flewell. COX = cyclooxygenase; CRP = C-reactive protein.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement